Atlas Trials

Lenalidomide in Combination With Melphalan and Dexamethasone in Newly-diagnosed Light-chain (AL)-Amyloidosis

Clinical trial NCT00621400 · COMPLETED

Trial details

NCT number
NCT00621400
Sponsor
Nantes University Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Amyloidosis
Start date
2008-01-01
Primary completion
2009-12-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.